TY - JOUR
T1 - Inhibition by tetanus toxin of sodium-dependent, high-affinity [3H]5-hydroxytryptamine uptake in rat synaptosomes
AU - Inserte, Javier
AU - Najib, Abderrahim
AU - Pelliccioni, Patricia
AU - Gil, Carles
AU - Aguilera, José
N1 - Funding Information:
This work was supported in part by Grant FIS 95/1737 from the Ministerio de Sanidad y Consumo. We thank Professor Ephraim Yavin, Dr. Jordi Ortiz, and Gemma Reverter for discussions and review of the manuscript.
Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1999/1/1
Y1 - 1999/1/1
N2 - Tetanus toxin (TeTx) is a powerful clostridial neurotoxin that inhibits Ca2+-dependent neurotransmitter secretion as do the botulinum neurotoxins (BoNTs). We found that TeTx (but not BoNT/A) produced a specific time- and dose-dependent inhibition of Na+-dependent [3H]5-hydroxytryptamine (serotonin, 5-HT) uptake in rat CNS synaptosomes. This effect was found in all CNS tryptaminergic areas, being maximal in the hippocampus and occipital cortex. TeTx produced the maximum reduction in [3H]5-HT uptake after 30 min of preincubation, being significant also at lower doses (10-12 M) or shorter incubation times (10 min). Serotonin transport inhibitors such as fenfluramine (IC50, 11.0 ± 0.9 μM), paroxetine (IC50, 33.5 ± 0.1 μM), and imipramine (IC50, 89.9 ± 5.7 μM) were 3 or 4 orders of magnitude less potent than TeTx (IC50, 8.7 ± 1.0 nM). Of the two fragments of TeTx, (the C-terminal portion of the neurotoxin heavy chain, which is responsible for the binding to the nerve tissue) was consistently more effective than the L- H(N) fragment (the light neurotoxin chain disulfide linked to the N-terminal portion of the heavy chain, which is responsible for the toxic metalloprotease action) as inhibitor of [3H]5-HT uptake in synaptosomal preparations (56 ± 5% and 95 ± 3% with respect to control, respectively). Antagonism of the toxin-induced [3H]5-HT uptake blockade could not be reversed by zinc chelators but did have the ability to antagonize the TeTx inhibition of basal and K+-evoked [3H]5-HT release in rat synaptosomes. The reduction in serotonin accumulation induced by TeTx could be responsible for some tetanic symptoms that have been related to the serotonergic system.
AB - Tetanus toxin (TeTx) is a powerful clostridial neurotoxin that inhibits Ca2+-dependent neurotransmitter secretion as do the botulinum neurotoxins (BoNTs). We found that TeTx (but not BoNT/A) produced a specific time- and dose-dependent inhibition of Na+-dependent [3H]5-hydroxytryptamine (serotonin, 5-HT) uptake in rat CNS synaptosomes. This effect was found in all CNS tryptaminergic areas, being maximal in the hippocampus and occipital cortex. TeTx produced the maximum reduction in [3H]5-HT uptake after 30 min of preincubation, being significant also at lower doses (10-12 M) or shorter incubation times (10 min). Serotonin transport inhibitors such as fenfluramine (IC50, 11.0 ± 0.9 μM), paroxetine (IC50, 33.5 ± 0.1 μM), and imipramine (IC50, 89.9 ± 5.7 μM) were 3 or 4 orders of magnitude less potent than TeTx (IC50, 8.7 ± 1.0 nM). Of the two fragments of TeTx, (the C-terminal portion of the neurotoxin heavy chain, which is responsible for the binding to the nerve tissue) was consistently more effective than the L- H(N) fragment (the light neurotoxin chain disulfide linked to the N-terminal portion of the heavy chain, which is responsible for the toxic metalloprotease action) as inhibitor of [3H]5-HT uptake in synaptosomal preparations (56 ± 5% and 95 ± 3% with respect to control, respectively). Antagonism of the toxin-induced [3H]5-HT uptake blockade could not be reversed by zinc chelators but did have the ability to antagonize the TeTx inhibition of basal and K+-evoked [3H]5-HT release in rat synaptosomes. The reduction in serotonin accumulation induced by TeTx could be responsible for some tetanic symptoms that have been related to the serotonergic system.
KW - 5-hydroxytrytamine(serotonin
KW - Release
KW - Synaptosomes
KW - Tetanus toxin
KW - Uptake
UR - http://www.scopus.com/inward/record.url?scp=0032921798&partnerID=8YFLogxK
U2 - 10.1016/S0006-2952(98)00281-0
DO - 10.1016/S0006-2952(98)00281-0
M3 - Article
C2 - 9920291
SN - 0006-2952
VL - 57
SP - 111
EP - 120
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 1
ER -